Cocrystal Pharma, Inc. — Balance Sheet Charts
31 snapshots of history · ending 2020-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+90.1% +$26M
$54M
Current Assets↑+310.8% +$26M
$34M
Cash & Equivalents↑+345.0% +$26M
$33M
ST Investments↓-86.4% -$6M
$993K
Receivables↓-13.7% -$88K
$556K
Inventory
$2M
Net PPE↑+37.1% +$160K
$591K
Goodwill↑+0.0% +$0
$19M
Intangibles
$148K
Total Liabilities↓-38.5% -$1M
$2M
Current Liabilities↓-40.6% -$928K
$1M
Account Payables↓-56.5% -$854K
$657K
Long-Term Debt↓-23.5% -$15M
$50M
Stockholders Equity↑+104.2% +$27M
$53M
Retained Earnings↓-4.1% -$10M
$-245M
Operating Lease ROU Asset↓-26.4% -$179K
$498K
Operating Lease Liability↓-25.3% -$177K
$523K
Finance Lease ROU Asset
—
Gross PP&E↑+13.1% +$198K
$2M
Accumulated Depreciation↑+3.5% +$38K
$1M
Total Debt Carrying Amount↓-23.5% -$15M
$50M